ANTIPODES PARTNERS Ltd

Position in WAT — Waters Corp /De/

CIK 1652442 ROYAL EXCHANGE, C3

Position in WAT

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$110,186

+$43,716 QoQ

Shares Held

370

+111.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ANTIPODES PARTNERS Ltd holds $32,110,014 across 4 Diagnostics & Research names. WAT ranks #2 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DGX	Quest Diagnostics Inc	162,589	$31,864,192
2	WAT	Waters Corp /De/ This page	370	$110,186
3	QGEN	Qiagen N.V.	1,989	$79,639
4	NTRA	Natera, Inc.	280	$55,997

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$110,186	370	+111.4%	Shares	Sole	2026-05-05
2025-12-31	$66,470	175	+98.9%	Shares	Sole	2026-02-05
2025-09-30	$26,383	88	+8.6%	Shares	Sole	2025-11-10
2023-03-31	$25,080	81	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.